Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-2800
Fax+1 214-645-8772
Dr. Lotan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterResidency, Urology, 1999 - 2003- University of Texas Southwestern Medical CenterResidency, Surgery, 1997 - 1999
Baylor College of MedicineClass of 1997
Certifications & Licensure
TX State Medical License 1999 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer Start of enrollment: 2016 Dec 01
- Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance Start of enrollment: 2019 Mar 11
- Join now to see all
Publications & Presentations
PubMed
- Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis.Zine-Eddine Khene, Raj Bhanvadia, Isamu Tachibana, Wadih Issa, William Graber
Clinical Genitourinary Cancer. 2025-04-01 - A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy.Joep J de Jong, James A Proudfoot, Siamak Daneshmand, Robert S Svatek, Vikram Narayan
BJU International. 2025-04-01 - Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive N...Jacob Taylor, Ashish M Kamat, Drupad Annapureddy, Zine-Eddine Khene, Jeffrey Howard
European Urology Oncology. 2025-04-01
Journal Articles
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018Ashish M Kamat, Yair Lotan, European Urology
Other
- Clinical presentation, diagnosis, and staging of bladder cancerLotan Y, Choueiri TK
http://www.uptodate.com/contents/clinical-presentation-diagnosis-and-staging-of-bladder-cancer
UpToDate, Wolters Kluwer Health - 2012-08-23
Authored Content
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
- Re: Who Should Be Investigated for Hematuria? Results of a Contemporary Prospective Observational Study of 3556 PatientsApril 2018
- Re: Who Should Be Investigated for Hematuria? Results of a Contemporary Prospective Observational Study of 3556 PatientsApril 2018
- Join now to see all
Press Mentions
HMN 2025: How Upper Urinary Tract Cancer Drug Might Provide Long-Term AdvantagesMarch 11th, 2025- Upper Urinary Tract Cancer Drug May Offer Long-Term BenefitsMarch 10th, 2025
- New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer ResearchFebruary 14th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
